First Choice Healthcare Solutions (OTC: FCHS) engages in the provision of healthcare services in the United States. The company’s network of non-physician-owned medical centers offer musculoskeletal and rehabilitative care services specializing in orthopaedics, spine surgery, neurology, interventional pain management and ambulatory surgical care. It also provides ancillary and diagnostic services comprising magnetic resonance imaging, X-ray, … Continue reading “First Choice Healthcare Solutions, Inc. (FCHS) Starts Presentation at LD Micro 2017 Invitational”
Atossa Genetics (NASDAQ: ATOS) is a clinical-stage pharmaceutical company engaged in the development of novel therapeutics and delivery methods to treat breast cancer and other breast conditions. The company’s leading program utilizes patented intraductal microcatheters, which deliver pharmaceuticals through the breast milk ducts. In March 2016, Atossa initiated a Phase 2 clinical study of these … Continue reading “Atossa Genetics, Inc. (NASDAQ: ATOS) Starts Presentation at LD Micro 2017 Invitational”
Exactus (OTC: EXDI) is a life science company that engages in developing point-of-care (POC) diagnostics for measuring proteolytic enzymes in the blood. It develops products to make patient data available to healthcare providers in a way that is unmatched. Exactus addresses healthcare gaps with easy-to-use, portable devices that reduce the time required to return analysis … Continue reading “Exactus, Inc. (EXDI) Starts Presentation at LD Micro 2017 Invitational”
Cellectar Biosciences (NASDAQ: CLRB) is engaged in the development of targeted phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. It offers CLR 131, a PDC radiotherapeutic product candidate currently being evaluated in a phase I study for the treatment of relapse or refractory multiple myeloma; CLR 125, a cancer-targeting radiotherapeutic is under … Continue reading “Cellectar Biosciences, Inc. (NASDAQ: CLRB) Starts Presentation at LD Micro 2017 Invitational”
BioSig Technologies (OTC: BSGM) is a development-stage medical device company that engages in developing a technology platform to minimize noise and artifacts from cardiac recordings during electrophysiology studies and ablation. Its products under development includes PURE (Precise Uninterrupted Real-time evaluation of Electrograms) EP system, a surface electrocardiogram and intracardiac multichannel recording and analysis system that … Continue reading “BioSig Technologies, Inc. (BSGM) Starts Presentation at LD Micro 2017 Invitational”
Origin Agritech (NASDAQ: SEED) is an agricultural biotechnology company engaged in crop seed breeding and genetic improvement, seed production, processing, distribution, and related technical services in the People’s Republic of China. Origin Agritech was founded in 1997 and is headquartered in the Zhong-Guan-Cun (ZGC). As the first Chinese seed company with an in-house biotech research … Continue reading “Origin Agritech Ltd. (NASDAQ: SEED) Starts Presentation at LD Micro 2017 Invitational”
As the marijuana industry continues its brisk forward march — with cannabis now legalized in some form in 29 states as well as the District of Columbia — cannabis dispensaries and other businesses are still faced with the challenge of having no banking options currently available to them, which forces them to conduct cash transactions … Continue reading “SinglePoint’s (SING) Bitcoin Solution Could Solve Cannabis Industry’s Banking Problems”
Net Element (NASDAQ: NETE) yesterday said its PayOnline subsidiary has initiated payment acceptance services for international mobile network operator V-Tell. V-Tell will utilize various payment methods offered through the PayOnline platform, such as recurring billing and one-click payment solutions for V-Tell’s website and for its mobile application. V-Tell will additionally utilize the array of topnotch … Continue reading “Relationship with V-Tell Further Solidifies Net Element’s (NASDAQ: NETE) Position as Standout Global PaaS Provider”
SeeThruEquity has issued an update and $0.65 price target on shares of Innovus Pharmaceuticals, Inc. (OTCQB: INNV) following the company’s launch of AllerVarx™ in the U.S. and the report of financial results for the first quarter of 2017. Highlights from the report include revenue of $2.2 million, a 865% increase compared to $0.2 million for … Continue reading “NetworkNewsBreaks – SeeThruEquity Updates Coverage with $0.65 PT on Innovus Pharmaceuticals, Inc. (OTCQB: INNV)”
Following CytoSorbents Corp.’s (NASDAQ: CTSO) appointment of a new chief medical officer (CMO), Aegis Capital reiterated its ‘Buy’ rating and price target of $9 on shares of the company’s stock. The company recently named Dr. Eric G. Mortensen, M.D., Ph.D., as its new CMO, starting full-time tomorrow. Dr. Mortensen holds an M.D. from Harvard University … Continue reading “NetworkNewsBreaks – Aegis Capital Reiterates “Buy” Rating on CytoSorbents Corp. (NASDAQ: CTSO)”
